ADVFN - Advanced Financial Network.
HOME» NASDAQ » A » AMGN Stock Price » AMGN Stock News

Amgen Inc. Share News

 Amgen Inc. (mm) Stock Price
AMGN Stock Price
 Amgen Inc. (mm) Stock Chart
AMGN Stock Chart
 Amgen Inc. (mm) Stock News
AMGN Stock News
 Amgen Inc. (mm) Company Information
AMGN Company Information
 Amgen Inc. (mm) Stock Trades
AMGN Stock Trades

House Panel Seeks Information From Drug Cos. On Health Law Agreements With White House -Bloomberg

DOW JONES NEWSWIRES Republicans on the House Energy and Commerce Committee are seeking information from several large drug companies about their agreements with the Obama administration during the formation of the health-care reform law, Bloomberg News reported Friday, citing three people familiar with the talks. One of the people said the Republicans turned to direct negotiations with the companies after trade group Pharmaceutical Research and Manufacturers of America didn't cooperate, Bloomberg reported. The committee is seeking documents and other information from Pfizer Inc. (PFE), Merck & Co. (MRK), Amgen Inc. (AMGN), Abbott Laboratories (ABT) and AstraZeneca PLC (AZN), Bloomberg reported. Rep. Michael Burgess (R., Texas) told Bloomberg that "this has been like pulling teeth, trying to get information." A spokesman for PhRMA said "we have been cooperating with the committee on an ongoing basis since the investigation began," Bloomberg reported. Full story at http://www.bloomberg.com/news/2012-05-04/obama-deal-with-drugmakers-said-to-be-probed-by-house.html -Dow Jones Newswires; 212-416-2900

Stock News for Amgen Inc. (AMGN)
DateTimeHeadline
08/22/201609:00:00New Data Add To Understanding Of Repatha® (Evolocumab) In Multiple...
08/22/201608:50:00Eli Lilly, AstraZeneca Progress With Alzheimer's Drug
08/19/201616:14:16Current Report Filing (8-k)
08/11/201617:29:34Prospectus Filed Pursuant to Rule 424(b)(2) (424b2)
08/11/201606:06:00Free Writing Prospectus - Filing Under Securities Act Rules 163/433...
08/10/201608:27:19Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)
08/06/201603:03:00AbbVie Sues Amgen Over Humira -- WSJ
08/05/201616:57:00AbbVie Files Patent Suit Over Amgen's Copy of Humira -- Update
08/05/201614:50:00AbbVie Sues Amgen Over Humira
08/05/201614:33:00AbbVie Files Patent Suit Over Amgen's Copy of Humira
08/02/201619:30:00CVS Drops Coverage of 2 Branded Biotech Drugs in Favor of Copies
08/02/201618:47:00CVS Drops Coverage of 2 Branded Biotech Drugs in Favor of Copies
08/02/201610:28:00Advaxis Shares Higher on Collaboration Deal With Amgen
08/02/201608:00:00Amgen And Advaxis Enter Global Cancer Immunotherapies Collaboration
07/29/201616:50:00Quarterly Report (10-q)
07/28/201609:42:00U.S. Hot Stocks: Hot Stocks to Watch
07/27/201618:55:00Amgen Profit Rises 13%, 2016 Outlook Raised -- Update
07/27/201617:10:00Amgen Profit Rises 13%, 2016 Outlook Raised
07/27/201617:00:00Amgen Profit Rises 13%, 2016 Outlook Raised
07/27/201616:31:36Current Report Filing (8-k)

Amgen Inc. and other NASDAQ stock quotes are delayed by at least 20 minutes.
All other stock price and quote data is delayed by at least 15 minutes unless otherwise stated. By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2015 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US noad